These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13869568)

  • 1. [Changes in blood coagulability induced by direct anticoagulants during treatment with anti-vitamin K].
    BIZZI B; ROSSI L
    Haematol Lat; 1961; 4():273-87. PubMed ID: 13869568
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood-clotting and anticoagulants; vitamin K.
    JUBELIER RA
    Cinci J Med; 1947 Aug; 28(8):543. PubMed ID: 20255566
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?
    Dentali F; Galliazzo S; Zuretti F; Gianni M
    Intern Emerg Med; 2017 Dec; 12(8):1087-1089. PubMed ID: 28779447
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of sodium dextrothyroxine in patients receiving anticoagulants.
    OWENS JC; NEELY WB; OWEN WR
    N Engl J Med; 1962 Jan; 266():76-9. PubMed ID: 14482918
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparin or anticoagulants (vitamin K antagonists) in the long-term treatment of angina pectoris and for prevention of recurrences of myocardial infarct?].
    TAMCHES A
    Presse Med (1893); 1961 Apr; 69():767-8. PubMed ID: 13775099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current anticogulants].
    BERGOGNE C
    Sem Hop Ther Paris; 1962 Jun; 38():549-51. PubMed ID: 13867779
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vitamin K antagonists].
    Chabalier R; Lévy G
    Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin K antagonists in severe kidney disease associated with regulatory problems].
    Uhlemann H
    Internist (Berl); 2017 Sep; 58(9):1004. PubMed ID: 28795200
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation control with vitamin K antagonists: how well are we doing?
    Lane DA; Boos CJ; Lip GY
    Chest; 2006 May; 129(5):1122-4. PubMed ID: 16684999
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitamin K antagonists contraindicated in chronic kidney disease].
    Engels T
    Internist (Berl); 2017 Sep; 58(9):1005. PubMed ID: 28795199
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply: Is a Trial of Vitamin K Antagonists and Bisphosphonates Possible in IPF?
    Margaritopoulos GA; Antoniou KM
    Am J Respir Crit Care Med; 2017 Jan; 195(2):271-272. PubMed ID: 28084829
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K antagonists in anticoagulant therapy of patients with cancer.
    Pasierski T
    Pol Arch Med Wewn; 2012; 122(1-2):60-4. PubMed ID: 22353708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antidotes for reversal of old and new oral anticoagulants.
    Suryanarayan D; Schulman S
    Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
    Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of blood coagulation factors between patients with gastrointestinal or intracranial bleeding under vitamin K antagonists.
    Moustafa F; Saint-Denis J; Laporte S; Mismetti P; Schmidt J
    Eur J Intern Med; 2016 Sep; 33():e22-4. PubMed ID: 27209417
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology of drugs used in thromboembolism].
    Orzechowska-Juzwenko K
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1663-7. PubMed ID: 6679090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.